Showing results (491-500 of 593) with videos related to

Sort By:
Pageof 60
Brain : a Journal of Neurology|July 2, 1999
Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?M A Lee, S Smith, J Palace, et al.
Molecular Psychiatry|March 8, 2017
Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson's diseaseF Imperiale, F Agosta, E Canu, et al.
Neurology|July 9, 2008
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR Zivadinov, A T Reder, M Filippi, et al.
AJNR. American Journal of Neuroradiology|September 22, 2007
A three-year study of brain atrophy after autologous hematopoietic stem cell transplantation in rapidly evolving secondary progressive multiple sclerosisM A Rocca, T Mondria, P Valsasina, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 9, 2009
High frequency repetitive transcranial magnetic stimulation decreases cerebral vasomotor reactivityF Vernieri, P Maggio, F Tibuzzi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 22, 2012
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosisM Filippi, P Preziosa, E Pagani, et al.
Human Gene Therapy|June 2, 2001
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitisP L Poliani, H Brok, R Furlan, et al.
Lancet (London, England)|August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis GroupL Kappos, D Moeri, E W Radue, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2005
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatmentC Avolio, M Filippi, C Tortorella, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 18, 2014
Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosisC Gobbi, M A Rocca, E Pagani, et al.
Pageof 60